Tazobactam

CHEMBL404 Phase 4 Aprobado Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
300.3 g/mol
LogP
-2.0
Phase
4

This medication is a beta-lactamase inhibitor, meaning it protects antibiotics from being broken down by certain bacteria that have developed resistance. It is always combined with another antibiotic (such as piperacillin) rather than used alone, extending the antibiotic's ability to fight a broader range of serious infections. It is given intravenously in hospital settings for infections of the lungs, skin, urinary tract, and abdomen.

Peso molecular

300,2900 g/mol

LogP

-2,00

TPSA

131,00 Ų

Regla de cinco de Lipinski

Cumple

Áreas terapéuticas

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Estructura 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

C[C@]1(Cn2ccnn2)[C@H](C(=O)O)N2C(=O)C[C@H]2S1(=O)=O

InChI

InChI=1S/C10H12N4O5S/c1-10(5-13-3-2-11-12-13)8(9(16)17)14-6(15)4-7(14)20(10,18)19/h2-3,7-8H,4-5H2,1H3,(H,16,17)/t7-,8+,10+/m1/s1

Molecular Formula

C10H12N4O5S

HBD / HBA

1 / 7

Enlaces Rotables

3

Átomos Pesados

20

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Preguntas frecuentes

This medication is a beta-lactamase inhibitor, meaning it protects antibiotics from being broken down by certain bacteria that have developed resistance. It is always combined with another antibiotic (such as piperacillin) rather than used alone, extending the antibiotic's ability to fight a broader range of serious infections. It is given intravenously in hospital settings for infections of the lungs, skin, urinary tract, and abdomen.

Yes, Tazobactam is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL404. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 123630. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Aviso médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.